(Q30353217)

English

Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: an open-label, multicenter, single-arm, phase II study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: an open-label, multicenter, single-arm, phase II study (English)

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

multicenter clinical trial

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

hospitalization

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Visanu Thamlikitkul

7

object named as

Visanu Thamlikitkul

0 references

Charles van der Horst

3

object named as

Charles van der Horst

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Francisco M. Marty

object named as

Francisco M Marty

1

0 references

author name string

Choy Y Man

2

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Bruno Francois

4

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Denis Garot

5

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Rafael Mánez

6

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Visanu Thamlikitkul

7

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

José A Lorente

8

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Francisco Alvarez-Lerma

9

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

David Brealey

10

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Henry H Zhao

11

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Steve Weller

12

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Phillip J Yates

13

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Amanda F Peppercorn

14

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

language of work or name

0 references

publication date

27 August 2013

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

209

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

4

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

542-550

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Influenza A (H1N1)--past season's wonder flu in Vojvodina

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

Influenza-associated pneumonia among hospitalized patients with 2009 pandemic influenza A (H1N1) virus--United States, 2009.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

Zanamivir pharmacokinetics and pulmonary penetration into epithelial lining fluid following intravenous or oral inhaled administration to healthy adult subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

Duration of viral shedding in hospitalized patients infected with pandemic H1N1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

Statistical estimates of absenteeism attributable to seasonal and pandemic influenza from the Canadian Labour Force Survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

Critically Ill patients with 2009 influenza A(H1N1) in Mexico

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

Zanamivir: a review of clinical safety

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

Preclinical development of low toxicity drugs: focus on zanamivir, an anti-influenza drug

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

A primer on continuous renal replacement therapy for critically ill patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

3 June 2018

Patients with pandemic (H1N1) 2009 in intensive care units, Israel

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT467

21 January 2018

Critically ill patients with 2009 influenza A(H1N1) infection in Canada.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT467

21 January 2018

Clinical characteristics and outcomes of patients with 2009 influenza A(H1N1) virus infection with respiratory failure requiring mechanical ventilation

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT467

21 January 2018

Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT467

21 January 2018

Zanamivir: a significant reduction in viral load during treatment in military conscripts with influenza

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT467

21 January 2018

The pharmacokinetic principles behind scaling from preclinical results to phase I protocols

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT467

21 January 2018

Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047294

26 November 2018

Identifiers

10.1093/INFDIS/JIT467

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30353217&oldid=1580089120"